This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
When a person has problems remembering things, learning new things, concentrating, or making decisions that influence their daily lives, they are said to have cognitive impairment. Mild to severe cognitive impairment occurs. People with moderate cognitive impairment may perceive changes in their cognitive skills but continue to be able to carry out their daily activities. There is no single disease or condition that causes cognitive impairment, and it is not limited to a specific age group. Cognitive impairment can be caused by Alzheimer's disease and other dementias, as well as conditions including stroke, traumatic brain injury, and developmental difficulties. It is expensive to have a cognitive impairment. People with cognitive impairment are admitted to the hospital more than three times as often as people who are admitted for another reason. In the United States, Alzheimer's disease and related dementias are projected to be the third most expensive disease to treat.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of